A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.

NCT00502996 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: rituximab [MabThera/Rituxan]

Sponsor

Hoffmann-La Roche